BioCryst Pharmaceuticals
BCRX
#5073
Rank
HK$12.43 B
Marketcap
HK$59.06
Share price
-3.07%
Change (1 day)
-3.19%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : HK$3.47 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are HK$3.47 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$3.80 B-5.7%
2023-12-31HK$4.03 B-6.05%
2022-12-31HK$4.29 B-6.3%
2021-12-31HK$4.58 B76.75%
2020-12-31HK$2.59 B90.08%
2019-12-31HK$1.36 B18.72%
2018-12-31HK$1.14 B-17.44%
2017-12-31HK$1.39 B99.9%
2016-12-31HK$0.69 B-26.53%
2015-12-31HK$0.94 B-10.67%
2014-12-31HK$1.06 B180.18%
2013-12-31HK$0.37 B-14.89%
2012-12-31HK$0.44 B-30.27%
2011-12-31HK$0.63 B-25.04%
2010-12-31HK$0.85 B-22.74%
2009-12-31HK$1.10 B68.46%
2008-12-31HK$0.65 B-41.19%
2007-12-31HK$1.11 B108.91%
2006-12-31HK$0.53 B-30.78%
2005-12-31HK$0.76 B204.97%
2004-12-31HK$0.25 B8.16%
2003-12-31HK$0.23 B-27.57%
2002-12-31HK$0.32 B-30.11%
2001-12-31HK$0.46 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
HK$22.75 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$27.18 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$68.66 M-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$9.18 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$455.49 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$5.04 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$641.68 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
HK$11.36 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$0.15 B-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA